Xanthophyllum fragrans C.T. White Leaf Extracts Inhibit the Growth of Pseudomonas aeruginosa

groupview

Abstract
Pharmacognosy Communications,2019,9,3,xx-xx.
Published:June 2019
Type:Original Article

Xanthophyllum fragrans C.T. White Leaf Extracts Inhibit the Growth of Pseudomonas aeruginosa

Lindiwe Mpala1, Getmore Chikowe1, Ian Edwin Cock1,2,*

1School of Environment and Science, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

2Environmental Futures Research Institute, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

Abstract:

Introduction: Xanthophyllum fragrans C.T. White is a rainforest tree that is native to north-eastern regions of Australia. X. fragrans leaf extracts were examined for the ability to inhibit the growth of Pseudomonas aeruginosa. Methods: The antimicrobial activity of a methanolic X. fragrans leaf extracts were investigated by disc diffusion and growth time course assays against P. aeruginosa. The growth inhibitory activity was further quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: The methanolic X. fragrans leaf extract was a potent inhibitor of P. aeruginosa growth (MICs of 430 and 1687μg/mL against the reference and clinical strains respectively). The aqueous X. fragrans leaf extract was also a moderate inhibitor of P. aeruginosa growth (MICs approximately 1000 and 2500μg/mL against the reference and clinical bacterial strains respectively). The antibacterial activities of the methanolic X. fragrans leaf extracts were further investigated using growth time course assays that showed significant growth inhibition in cultures of P. aeruginosa within 1 h of exposure. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for use in preventing diseases caused by these pathogens. Conclusion: The lack of toxicity of the X. fragrans leaf extracts and their growth inhibitory bioactivity against P. aeruginosa indicates their potential in the development of new therapies targeting this bacterium.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.